(Q46088369)

English

Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study

scientific article published in March 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study (English)

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

0 references

1 reference

based on heuristic

inferred from title

4

object named as

Karen S Pieper

1 reference

Europe PubMed Central

19 December 2017

David J Moliterno

2

object named as

David J Moliterno

1 reference

Europe PubMed Central

19 December 2017

Kenneth W Mahaffey

11

object named as

Kenneth W Mahaffey

1 reference

Europe PubMed Central

19 December 2017

Robert A Harrington

14

object named as

Robert A Harrington

1 reference

Europe PubMed Central

19 December 2017

Frans Van de Werf

object named as

Frans Van de Werf

12

0 references

Richard C Becker

1

object named as

Richard C Becker

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

5

object named as

Jinglan Pei

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

9

object named as

John Strony

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

7

object named as

Khaled M Ziada

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

13

object named as

Enrico Veltri

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

author name string

Lisa K Jennings

3

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

Alan Niederman

6

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

Gail Berman

8

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

Diane Joseph

10

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

TRA-PCI Investigators

15

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

language of work or name

0 references

publication date

1 March 2009

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

373

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

9667

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

919-928

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombin receptor antagonists; recent advances in PAR-1 antagonist development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional significance of adenosine 5'-diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet adhesion and signaling induced by the octapeptide primary binding sequence (KOGEOGPK) from type III collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of fondaparinux and enoxaparin in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical inhibition of the seven-transmembrane thrombin receptor (PAR1) by intravenous aprotinin during cardiothoracic surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960230-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(09)60230-0

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19286091

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46088369&oldid=2091504485"